Sign Up to like & get recommendations! 0
Published in 2018 at "Diabetes Therapy"
DOI: 10.1007/s13300-018-0513-2
Abstract: IntroductionThe prospective, non-interventional OCEAN study examined the use of intravitreal ranibizumab injections for the treatment of diabetic macular oedema (DME) in a real-world setting in Germany.MethodsAdults with DME receiving ≥ 1 ranibizumab (0.5 mg) injections were recruited by… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "American Journal of Ophthalmology Case Reports"
DOI: 10.1016/j.ajoc.2016.10.009
Abstract: Purpose To report the occurrence and management of severe infectious scleritis in a 75 year-old woman following intravitreal ranibizumab injection. Observations A 75 year-old monocular woman receiving monthly intravitreal ranibizumab injection for wet age related… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Ocular Immunology and Inflammation"
DOI: 10.1080/09273948.2016.1247175
Abstract: ABSTRACT Purpose: To describe the clinical outcomes of intravitreal ranibizumab treatment for subfoveal choroidal neovascularization (CNV) associated with multiple evanescent white dot syndrome (MEWDS). Methods: This is a prospective, interventional, case series. All recruited patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Ocular immunology and inflammation"
DOI: 10.1080/09273948.2020.1767793
Abstract: PURPOSE The purpose of this study is to report a case of herpetic keratouveitis that developed soon after intravitreal ranibizumab injection. CASE REPORT A 54-year-old man with bilateral proliferative diabetic retinopathy and severe macular edema… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Cutaneous and Ocular Toxicology"
DOI: 10.1080/15569527.2017.1300160
Abstract: Abstract Purpose: To assess the results of intravitreal ranibizumab treatment for retinopathy of prematurity (ROP) in infants. Methods: A single-institution, retrospective consecutive case series. Results: Thirty-one patients who received ranibizumab treatment for ROP were evaluated… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Acta Ophthalmologica"
DOI: 10.1111/aos.14282
Abstract: To determine the feasibility of a definitive study of intravitreal ranibizumab to promote the clearance of persistent diabetic vitreous haemorrhage and thereby avoid vitrectomy. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Acta Ophthalmologica"
DOI: 10.1111/aos.15283
Abstract: To compare the effects of monotherapy with intravitreal ranibizumab, aflibercept and bevacizumab on retinal ganglion cell layer (RGCL) and retinal nerve fibre layer (RNFL) in patients with naïve neovascular age‐related macular degeneration (nAMD). read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "British Journal of Ophthalmology"
DOI: 10.1136/bjophthalmol-2018-312272
Abstract: Background/Aims To compare the efficacy, anatomical outcomes and complications of intravitreal ranibizumab with those of laser photocoagulation for retinopathy of prematurity (ROP). Methods This is a retrospective case series of 314 eyes from 165 infants… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of Ophthalmology"
DOI: 10.1155/2020/2561251
Abstract: The aim of this study was to compare the effectiveness of intravitreal ranibizumab (IVR) injections for the treatment of diabetic macular edema (DME) in eyes with and without previous vitrectomy. The medical records of 28… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Ophthalmologica"
DOI: 10.1159/000477180
Abstract: Purpose: The aim of this paper was to assess and compare the effects of intravitreal ranibizumab and bevacizumab on retinal vessel diameter in eyes with neovascular age-related macular degeneration (AMD). Methods: Patients with neovascular AMD… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Ophthalmologica"
DOI: 10.1159/000478030
Abstract: Purpose: To compare two different initial dosing regimens of intravitreal ranibizumab used to treat myopic choroidal neovascularization. Methods: A total of 61 eyes of 56 patients were treated: 26 eyes received a single injection followed… read more here.